What Conditions Are Caused by Type 2 Inflammation?

April 24, 2023

Type 2 inflammation is a biological reaction that occurs in response to allergens and other irritants. This type of inflammation is characterized by the production of various inflammatory signals and proliferation of immune cells involved in the inflammatory response.

 

Read on to learn the different conditions caused by type 2 inflammation.


Conditions caused by type 2 inflammation:

1) Asthma

Asthma is a chronic respiratory condition characterized by inflammation of the airways. The inflammation results in swelling and narrowing of the airways, which makes it difficult for air to flow in and out of the lungs. Allergens, such as pollen, dust mites, and animal dander, and other irritants, such as smoke and air pollution, often trigger it.

 

Type 2 inflammation is a key feature of asthma. It affects up to 51% of patients with uncontrolled asthma and 55–70% of patients with severe asthma. It is characterized by the activation of Th2 cells, which produce cytokines such as interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-13 (IL-13). These cytokines promote the production of immunoglobulin E (IgE) antibodies, which bind to allergens and trigger the release of inflammatory mediators such as histamine.


2) Atopic Dermatitis

Atopic dermatitis, also known as eczema, is a chronic inflammatory skin condition that affects approximately 10-20% of children and 1-3% of adults worldwide. The condition is characterized by dry, itchy, and inflamed skin, often in the creases of the elbows or behind the knees. Type 2 inflammation is a major contributor to atopic dermatitis.


3) Chronic Rhinosinusitis with Nasal Polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory condition of the nasal and sinus cavities. Type 2 inflammation plays a significant role in the development of CRSwNP. It is characterized by the presence of nasal polyps, which are small, grape-like growths in the lining of the nasal passages. The symptoms of CRSwNP are nasal congestion, runny nose, facial pain, and loss of smell.


4) Eosinophilic Esophagitis

Type 2 inflammation contributes significantly to Eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. The presence of a high number of eosinophils, a type of immune cell, in the esophageal tissues characterizes the condition. EoE is associated with symptoms such as difficulty swallowing, chest pain, and food impaction. Food allergens like milk, soy, wheat, and eggs often trigger it.


Treatment Options for Type 2 Inflammatory Conditions

Type 2 inflammatory conditions can be challenging to manage, and treatment often involves a combination of medications and lifestyle changes. Treatment aims to reduce inflammation, alleviate symptoms, and prevent complications.

 

Corticosteroids are often used to treat type 2 inflammatory conditions. They work by reducing inflammation and suppressing the immune response. Depending on the treated condition, they can be taken orally, inhaled, or applied topically.

 

Lifestyle changes can also help manage type 2 inflammatory conditions. Avoiding allergens and other triggers can reduce symptoms and prevent exacerbations. For example, patients with asthma should avoid exposure to smoke, air pollution, and other irritants. Patients with atopic dermatitis should avoid harsh soaps, fragrances, and other irritants. In addition, maintaining a healthy diet and exercise regimen can help reduce inflammation and improve overall health.

 

Know more about type 2 inflammation or any other condition affecting the airways from Snot Force Alliance! We bring together doctors and medical professionals to collaborate, innovate, and inspire the best of the medical community involved in treating nose, sinus, and airway conditions. Join the talented group today to learn and share!


Doctor and patient reviewing a sinus ct scan beside a medical scan display
October 13, 2026
Learn how ENT doctors can approach complex cases when standard treatment algorithms fall short, using collaboration, research, and personalized airway care.
September 22, 2026
Inflammatory airway diseases can impact a patient's quality of life. Untreated conditions leave patients struggling to breathe, coughing regularly, and feeling unwell for months at a time. Airway disease management has undergone significant changes in recent years. Treating airway diseases has become increasingly complex, despite improvements in methodologies and technologies. In rural and underserved regions, many patients lack access to specialty care. Key Takeaways: Providing high-quality care to patients with airway disease requires collaboration across specialties. It is important to expand rural ENT access and access to multidisciplinary clinics. Clinicians in rural communities can improve patient outcomes through collaborations and with creative solutions that expand airway care. The Need for Multidisciplinary Airway Care Airway diseases affect multiple systems of the body and thus are treated by different types of physicians. Allergists, primary care doctors, pulmonologists, and ENT physicians all play a role in caring for patients with airway conditions. Physicians who can facilitate multidisciplinary care can improve diagnostic accuracy while also helping to ensure better patient outcomes. Challenges in Rural and Underserved Communities Rural ENT access is spotty at best. Many rural areas lack specialty physicians and often, patients must travel long distances to tertiary medical centers where they receive care. As a result, patients with limited transportation options may experience delays in diagnosis and care. Sometimes, these specialty care disparities can leave primary care providers to manage complex airway conditions on their own. In areas where insurance coverage is limited, and referral networks are fragmented, patients may struggle with their conditions without treatment at all. The Consequences of These Limitations Delays in diagnosis and treatment mean poor management of chronic conditions and increased reliance on treatment from acute care settings. Under this system, patients become frustrated as they lean on ineffective treatment methods. Methods for Expanding Access There are many methods for expanding access to patients in rural and underserved areas. Telehealth Airway Care The use of telehealth treatment has significantly expanded in recent years. With telehealth tools, hybrid care models combine in-person and virtual visits. This same technology also connects doctors, bringing together specialists and community clinicians. Regional Centers of Excellence Multidisciplinary airway centers have proven effective for helping patients access specialty care. Airway centers make it easier to streamline referrals in complex cases. These airway centers can serve larger geographic areas by setting up outreach clinics in surrounding communities. Collaborative Networks Partnerships and collaborations between physicians are key to ensuring that primary care providers in underserved areas have access to resources and information. Supporting Rural Physicians There are many ways to support rural physicians. Snot Force has committed to build networks for physicians, helping to ensure the dissemination of information across specialties and practice settings. We facilitate collaboration between disciplines to promote innovation in care for underserved communities. We're bringing doctors together to break down specialty care disparities and improve rural ENT access and information. Our research collaborative depends on many medical professionals to participate, and we're always looking for more physicians to join the force. To learn more, contact Snot Force today .
doctors discussing how AI helps
September 10, 2026
Explore the ethical considerations of AI-guided airway care, including clinical judgment, patient consent, bias, safety, data privacy, and validation.
Unified airway awareness logo
August 25, 2026
Discover how biologics, multidisciplinary care, and precision medicine are shaping the future of unified airway care and chronic airway disease management over the next five years.
anatomy-of-paranasal-sinuses-and-trachea-airway-3d-illustration
August 11, 2026
Explore emerging tools in functional airway assessment, including quantitative CT, airway imaging, airflow modeling, and advanced sinus diagnostics shaping the future of ENT and airway care.
A doctor reviewing a patient chart on a clipboard, representing clinical decision-making for chronic
July 28, 2026
Compare surgery, biologics, and medical management for chronic sinusitis. Learn how clinicians choose the best treatment for CRS and nasal polyps.
Woman in a face mask holding a flower to her nose, illustrating smell loss from chronic sinusitis.
July 16, 2026
Learn why smell loss in chronic sinusitis may signal severe airway disease, nasal polyps, or eosinophilic inflammation, and explore today's treatment options.
doctors training each other
July 7, 2026
Learn why interdisciplinary training in CRS, asthma, biologics, and airway inflammation is essential for preparing clinicians to diagnose and manage complex airway disease.
a group of physicians in a meeting
June 26, 2026
Learn how standardized communication across ENT, allergy, pulmonology, and GI specialties improves care coordination, teamwork, and patient outcomes.
participants-learning-new-ultrasound-techniques-on-medical-congress
May 26, 2026
Discover how translational airway research improves real-world patient care through collaboration, innovation, and evidence-based sinus treatment. Learn how Snot Force helps physicians bridge the gap between airway science and clinical practice.